Search for: "Regeneron"
Results 21 - 40
of 224
Sort by Relevance
|
Sort by Date
31 Jul 2023, 1:18 am
Further readingKymab caught the mouse as sufficiency strengthened by UK Supreme Court in Regeneron battle ([2020] UKSC 27) (June 2020)Shining the light on insufficiency (T 1285/15) (August 2020)Illumina v MGI Part 1: Mr Justice Birss on sufficiency, DNA sequencing and chocolate teapots (Feb 2021)US Supreme Court decision in Amgen v Sanofi: The European Perspective (May 2023)Sufficiency of broad functional genus and first medical use claims in Europe (T 0424/21) (Oct… [read post]
25 Jul 2023, 9:05 pm
The briefs provide arguments separately on the purported scientific (by several noted scientists*) and legal (by Regeneron Pharmaceuticals, Inc.) errors the Board made in arriving at its decision. [read post]
10 Jun 2023, 4:02 pm
In Regeneron, the applicant had a good idea. [read post]
9 Jun 2023, 8:36 am
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
9 Jun 2023, 8:36 am
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
8 Jun 2023, 7:43 am
The Federal Trade Commission (FTC) recently announced that it would seek to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
8 Jun 2023, 7:43 am
The Federal Trade Commission (FTC) recently announced that it would seek to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
15 May 2023, 1:47 am
On January 26, 2023, Regeneron Pharmaceuticals, Inc., who sought to invalidate Amgen Inc. [read post]
19 Feb 2023, 9:16 pm
Noonan -- Sanofi and Regeneron filed their brief at the Supreme Court in Amgen v. [read post]
17 Jan 2023, 12:00 am
According to Sweet & Maxwell, in addition to the major changes prompted by Brexit, other new features include: • Reviews the Supreme Court decisions in Warner Lambert v Generics and Regeneron v Kymab on insufficiency and plausibility• Commentary on the CJEU decision in Santen SAS v DGINPI on SPCs• A new section concerning IPR disputes between employers and employees• Overhaul of the chapter on Article 102 as to when exercising IPRs may amount to an abuse of a… [read post]
12 Jan 2023, 7:00 am
Guest Post by Professor Jorge L. [read post]
3 Jan 2023, 5:58 pm
“We are working hard to get new mAbs available as quickly as we can in a scientifically sound and safe way,” says Christos Kyratsous, who heads infectious disease research at the biotech company Regeneron. [read post]
15 Dec 2022, 11:18 am
During the height of the pandemic, Regeneron made this treatment available to as many patients as possible in the United States. [read post]
27 Nov 2022, 8:10 pm
Paul Berghoff of McDonnell Boehnen Hulbert & Berghoff LLP will moderate a panel consisting of Larry Coury of Regeneron Pharmaceuticals, Inc.; Stephanie Donahue of Sanofi; Henry Hadad of Bristol-Meyers Squibb Co.; and Stuart Watt of Amgen, Inc. that will discuss the issues and arguments concerning the current state of enablement and written description law and where the law may be headed. [read post]
16 Nov 2022, 7:42 pm
Regeneron's argument was based on its assertion that the PTAB had misapplied the law regarding conception; the... [read post]
10 Nov 2022, 9:39 am
Amgen had sued Sanofi and Regeneron Pharmaceuticals (collectively, “Sanofi”) over their cholesterol drug Praluent, which competes with Amgen’s drug Repatha. [read post]
20 Apr 2022, 11:14 am
The post Regeneron Captures New Piece For Cancer With $250M Checkmate Pharma Buyout appeared first on Above the Law. [read post]
8 Apr 2022, 2:05 am
Counsel/Corporate Counsel, Commercial Transactions/Strategic Partnerships, Roofstock (San Francisco, CA) Associate General Counsel – Global Head of IP, www.princetonlegal.com (Princeton, NJ) AGC – Rapidly Growing Startup Healthcare Company, Beacon Hill Staffing Group (Boston, MA) In-House Corporate Counsel (full-time remote engagement), Latitude (New York, NY) Legal Counsel & Global Copyright Manager, Christie’s (New York, NY) Director, Corporate Counsel – R&D,… [read post]
8 Feb 2022, 7:53 am
Regeneron alleged that they would not. [read post]
25 Jan 2022, 7:51 am
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant, U.S. health regulators said. [read post]
